UPDATE 1-GSK files potential $1 bln shingles vaccine for U.S. approval

* Consensus forecasts point to $1.05 billion sales in 2021 (Adds sales forecast, background on rival vaccines)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.